Earnest Partners LLC Has $95.40 Million Holdings in Plexus Corp. $PLXS

Key Points

• Earnest Partners LLC reduced its holdings in Plexus Corp. by 1.8%, owning about 744,535 shares valued at approximately $95.40 million as of the most recent quarter.
• Insider transactions included CEO Todd P. Kelsey selling 1,500 shares, while overall insider sales exceeded 8,400 shares worth over $1 million in the last three months.
• Plexus Corp. reported earnings per share of $1.90 for the last quarter, exceeding estimates, and analysts predict an average of 5.9 EPS for the current year.

Earnest Partners LLC cut its holdings in Plexus Corp. (NASDAQ:PLXS - Free Report) by 1.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 744,535 shares of the technology company's stock after selling 13,996 shares during the period. Earnest Partners LLC owned about 2.75% of Plexus worth $95,397,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in shares of Plexus by 0.6% in the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 975,612 shares of the technology company's stock valued at $125,005,000 after acquiring an additional 6,257 shares during the period. American Century Companies Inc. boosted its position in shares of Plexus by 24.7% in the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company's stock valued at $86,901,000 after acquiring an additional 134,205 shares during the period. Nuveen Asset Management LLC boosted its position in shares of Plexus by 6.6% in the fourth quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company's stock valued at $55,012,000 after acquiring an additional 21,911 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of Plexus by 120.4% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company's stock valued at $44,655,000 after acquiring an additional 190,360 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Plexus by 10.0% in the fourth quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock valued at $51,967,000 after acquiring an additional 30,163 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $125.63, for a total transaction of $188,445.00. Following the completion of the sale, the chief executive officer owned 72,214 shares of the company's stock, valued at approximately $9,072,244.82. This represents a 2.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Michael J. Running sold 646 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $130.05, for a total value of $84,012.30. Following the transaction, the insider owned 630 shares in the company, valued at $81,931.50. The trade was a 50.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,426 shares of company stock worth $1,090,866. Company insiders own 1.76% of the company's stock.

Plexus Stock Performance

Plexus stock opened at $136.56 on Wednesday. The business has a 50 day moving average of $132.67 and a 200-day moving average of $130.00. Plexus Corp. has a 1 year low of $103.43 and a 1 year high of $172.89. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.74. The company has a market capitalization of $3.69 billion, a P/E ratio of 23.26 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the firm posted $1.45 earnings per share. The firm's revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities research analysts predict that Plexus Corp. will post 5.9 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Benchmark reissued a "buy" rating and issued a $160.00 target price on shares of Plexus in a research report on Wednesday, June 4th. Wall Street Zen cut shares of Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Stifel Nicolaus set a $140.00 price objective on shares of Plexus in a research report on Thursday, July 24th. Needham & Company LLC cut their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Finally, Sidoti raised shares of Plexus from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $135.00 to $150.00 in a research report on Friday, July 25th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Plexus presently has a consensus rating of "Moderate Buy" and an average price target of $152.00.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.